Direct Effects of Glucagon-Like Peptide-1 on Myocardial Contractility and Glucose Uptake in Normal and Postischemic Isolated Rat Hearts
Open Access
- 17 February 2006
- journal article
- Published by American Society for Pharmacology & Experimental Therapeutics (ASPET) in The Journal of pharmacology and experimental therapeutics
- Vol. 317 (3), 1106-1113
- https://doi.org/10.1124/jpet.106.100982
Abstract
Recent evidence suggests that glucagon-like peptide-1 (GLP-1) enhances recovery of left ventricular (LV) function after transient coronary artery occlusion. However, it is uncertain whether GLP-1 has direct effects on normal or ischemic myocardium and whether the mechanism involves increased myocardial glucose uptake. LV function and myocardial glucose uptake and lactate production were measured under basal conditions and after 30 min of low-flow ischemia and 30 min of reperfusion in the presence and absence of GLP-1-(7–36) amide. The response was compared with standard buffer alone or buffer containing insulin (100 μU/ml). GLP-1 decreased the left ventricular developed pressure (baseline: 100 ± 2 mm Hg; GLP-1: 75 ± 3 mm Hg, p < 0.05) and LV dP/dt (baseline: 4876 ± 65 mm Hg/s; GLP-1: 4353 ± 76 mm Hg/s, p < 0.05) in normal hearts. GLP-1 increased myocardial glucose uptake (baseline: 33 ± 3 μmol/min/g; GLP-1: 81 ± 7 μmol/min/g, p < 0.05) by increasing nitric oxide production and glucose transporter (GLUT)-1 translocation. GLP-1 enhanced recovery after 30 min of low-flow ischemia with significant improvements in LV end-diastolic pressure (control: 13 ± 4 mm Hg; GLP-1: 3 ± 2 mm Hg, p < 0.05) and LV developed pressure (control: 66 ± 6 mm Hg; GLP-1: 98 ± 5 mm Hg, p < 0.05). GLP-1 increased LV function, myocardial glucose uptake, and GLUT-1 and GLUT-4 translocation during reperfusion to an extent similar to that with insulin. GLP-1 has direct effects on the normal heart, reducing contractility, but increasing myocardial glucose uptake through a non-Akt-1-dependent mechanism, distinct from the actions of insulin. However, GLP-1 increased myocardial glucose uptake and enhanced recovery of cardiac function after low-flow ischemia in a fashion similar to that of insulin.This publication has 24 references indexed in Scilit:
- Inhibition of CFTR channels by a peptide toxin of scorpion venomAmerican Journal of Physiology-Cell Physiology, 2004
- Gq/G13signaling by ET-1 in smooth muscle: MYPT1 phosphorylation via ETAand CPI-17 dephosphorylation via ETBAmerican Journal of Physiology-Cell Physiology, 2004
- Glucagon-Like Peptide-1 Limits Myocardial Stunning following Brief Coronary Occlusion and Reperfusion in Conscious CaninesThe Journal of pharmacology and experimental therapeutics, 2004
- Recombinant Glucagon-Like Peptide-1 Increases Myocardial Glucose Uptake and Improves Left Ventricular Performance in Conscious Dogs With Pacing-Induced Dilated CardiomyopathyCirculation, 2004
- Effects of Glucagon-Like Peptide-1 in Patients With Acute Myocardial Infarction and Left Ventricular Dysfunction After Successful ReperfusionCirculation, 2004
- The Glucagon-Like PeptidesEndocrine Reviews, 1999
- Myocardial Glucose Transporter GLUT1: Translocation Induced by Insulin and IschemiaJournal of Molecular and Cellular Cardiology, 1999
- Tissue distribution of messenger ribonucleic acid encoding the rat glucagon-like peptide-1 receptorEndocrinology, 1996
- Distribution of GLP-1 and PACAP receptors in human tissuesActa Physiologica Scandinavica, 1996
- Does Mitogen-Activated-Protein Kinase have a Role in Insulin Action?. The Cases for and AgainstJBIC Journal of Biological Inorganic Chemistry, 1995